ENSG Market Analysis
Wall Street coverage
third-party contextWall Street coverage
$220.00median target· current $179.37 (+22.7%)5 analysts
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
News & Sentiment
50 articles · sorted by datePage 1 of 3 · 50 total
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Fundamentals
Updated daily after market closeP/E ratio28.18Forward 23.20
EPS (TTM)$6.3716.7% YoY
Profit margin6.9%HEALTHCARE
Market cap$10.46BLarge cap
Valuation
- Forward P/E
- 23.20
- PEG ratio
- 1.55
- P/B
- 4.28
- P/S (TTM)
- 1.91
- EV/EBITDA
- 19.94
Profitability & growth
- ROE (TTM)
- 17.0%
- Operating margin
- 9.0%
- Revenue growth YoY
- 17.3%
- Dividend yield
- 0.1%
- Beta
- 0.69
Last earnings
Jul 27, 2026 · Estimate $1.63 · Reported $1.72
Analyst estimate. Actual results often differ.
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
About The Ensign Group Inc
Company profileThe Ensign Group, Inc. provides health care services in the post-acute care continuum and other ancillary businesses. The company is headquartered in San Juan Capistrano, California.
Classification
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 29222 RANCHO VIEJO ROAD, SAN JUAN CAPISTRANO, CA
- Fiscal year end
- December
- Latest quarter
- Jun 30, 2026
Market cap$10.46B
Shares outstanding$58.3M
52W high$217.84
52W low$141.52
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
Balanced Agent